BIOGEN.BO

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Investment - Banking & Investment Services

DCF fair valuemodel estimate

Intrinsic value

$0.63

Price

$0.28

Implied upside

+127%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
BIOGEN.BOBiogen Pharmachem Industries L	$0.28	+3.70%	$295M	—
BAMPSL.BOBampsl Securities Limited	$18.48	+0.00%	$629M	—
BNRSEC.BOB.N.Rathi Securities Limited	$17.15	+0.41%	$716M	—
DHANCOT.BODhanlaxmi Cotex Limited	$139.35	-1.97%	$679M	—
GOWRALE.BOGowra Leasing and Finance Limited	$85.99	+2.16%	$666M	—
JOINDRE.BOJoindre Capital Services Limited	$48.78	-0.45%	$675M	—
LADDERUP.BOLadderup Finance Limited	$62.82	-9.99%	$666M	—

Source: Financial Modeling Prep · peers by sector/industry

Biogen Pharmachem Industries L

Biogen Pharmachem Industries Ltd. began its operations on July 13, 1995, from its headquarters in Rajkot, India. The company's main business activity focuses on dealing in and trading various shares and securities.

www.biogenpharma.club

IPO / List date: Dec 30, 2024
HQ: IN

Held by traders on TradeandTell

No one on the platform currently holds BIOGEN.BO.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in BIOGEN.BO as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded BIOGEN.BO yet.